Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 EUR | 0.00% | +5.14% | 0.00% |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 58.61M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+48.37% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- PANG Stock
- News Pangaea Oncology, S.A.
- Pangaea Oncology, S.A. announced that it expects to receive €3.875 million in funding